Product NDC: | 67386-421 |
Proprietary Name: | Xenazine |
Non Proprietary Name: | tetrabenazine |
Active Ingredient(s): | 12.5 mg/1 & nbsp; tetrabenazine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67386-421 |
Labeler Name: | Lundbeck Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021894 |
Marketing Category: | NDA |
Start Marketing Date: | 20081124 |
Package NDC: | 67386-421-01 |
Package Description: | 112 TABLET in 1 BOTTLE (67386-421-01) |
NDC Code | 67386-421-01 |
Proprietary Name | Xenazine |
Package Description | 112 TABLET in 1 BOTTLE (67386-421-01) |
Product NDC | 67386-421 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | tetrabenazine |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20081124 |
Marketing Category Name | NDA |
Labeler Name | Lundbeck Inc. |
Substance Name | TETRABENAZINE |
Strength Number | 12.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes |